Tao Hou

发表

W. Willett, N. Cook, E. Riboli, 2019 .

Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of Coronavirus Disease 2019 (COVID-19) by label-free integrative pharmacology assays

Xinmiao Liang, Yuan-sheng Xiao, Hongli Jin, 2021, Journal of Ethnopharmacology.

Identification and target-pathway deconvolution of FFA4 agonists with anti-diabetic activity from Arnebia euchroma (Royle) Johnst.

Xinmiao Liang, Xiuli Zhang, Yanfang Liu, 2020, Pharmacological research.

Label-free cell phenotypic study of FFA4 and FFA1 and discovery of novel agonists of FFA4 from natural products

Xinmiao Liang, Han Zhou, Hai-long Piao, 2019, RSC advances.

Ursodesoxycholic acid is an FFA4 agonist and reduces hepatic steatosis via FFA4 signaling.

Jun Wang, Han Zhou, Yanfang Liu, 2022, European journal of pharmacology.

Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay

Xinmiao Liang, Han Zhou, Xiuli Zhang, 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.

Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.

Guohui Li, Ye Fang, Xinmiao Liang, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Discovery of novel antagonists on β2-adrenoceptor from natural products using a label-free cell phenotypic assay

Xinmiao Liang, Han Zhou, Xiuli Zhang, 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.

Systematic characterization of AT1 receptor antagonists with label-free dynamic mass redistribution assays.

Xinmiao Liang, Han Zhou, Xiuli Zhang, 2020, Journal of pharmacological and toxicological methods.

Synthesis and Evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic Acid and N-phenylbenzenesulfonamide Derivatives as FFA4 Agonists.

Xinmiao Liang, Han Zhou, Xiuli Zhang, 2020, Bioorganic & medicinal chemistry letters.

Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1.

Xinmiao Liang, Xiuli Zhang, Jixia Wang, 2016, Pharmacological research.

Integration of Two-Dimensional Liquid Chromatography-Mass Spectrometry and Molecular Docking to Characterize and Predict Polar Active Compounds in Curcuma kwangsiensis

Xinmiao Liang, Han Zhou, Yanfang Liu, 2022, Molecules.

Label-free cell phenotypic study of opioid receptors and discovery of novel mu opioid ligands from natural products.

Xinmiao Liang, Han Zhou, Xiuli Zhang, 2021, Journal of ethnopharmacology.

SAR Studies of N-[2-(1H-Tetrazol-5-yl)phenyl]benzamide Derivatives as Potent G Protein-Coupled Receptor-35 Agonists.

Ye Fang, Xinmiao Liang, Hai-long Piao, 2018, ACS medicinal chemistry letters.

Discovery of novel antagonists on β2-adrenoceptor from natural products using a label-free cell phenotypic assay

Xinmiao Liang, Han Zhou, Xiuli Zhang, 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.

Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles

Han Zhou, Pan Wang, Yanfang Liu, 2022, International journal of molecular sciences.

Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay.

Xinmiao Liang, Han Zhou, Xiuli Zhang, 2020, Journal of ethnopharmacology.

New delivery route of gambogic acid via skin for topical targeted therapy of cutaneous melanoma and reduction of systemic toxicity.

Wei Wang, Tao Hou, Chao Wang, 2020, Journal of pharmaceutical sciences.

Anti-gastric cancer activity in three-dimensional tumor spheroids of bufadienolides

Xinmiao Liang, Xiuli Zhang, Yanfang Liu, 2016, Scientific Reports.

Analgesic bisbenzylisoquinoline alkaloids from the rhizoma of Menispermum dauricum DC.

Xinmiao Liang, Xiuli Zhang, Yanfang Liu, 2020, Bioorganic chemistry.

Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay

Xinmiao Liang, Xiuli Zhang, Jixia Wang, 2015 .

Discovery of 2H-Chromen-2-one Derivatives as G Protein-Coupled Receptor-35 Agonists.

Ye Fang, Xinmiao Liang, Xiuli Zhang, 2017, Journal of medicinal chemistry.

Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay.

Xinmiao Liang, Han Zhou, Yanfang Liu, 2022, Chemico-biological interactions.

Corybungines A-K: Isoquinoline alkaloids from Corydalis bungeana with dopamine D2 receptor activity.

Han Zhou, Zi-Hui Zhang, Jixia Wang, 2022, Phytochemistry.

Uncariphyllin A-J, indole alkaloids from Uncaria rhynchophylla as antagonists of dopamine D2 and Mu opioid receptors.

Xinmiao Liang, Yanfang Liu, Jixia Wang, 2022, Bioorganic chemistry.

Design and synthesis of 2-(2,2-diarylethyl)-cyclamine derivatives as M3 receptor antagonists and functional evaluation on COPD.

Xinmiao Liang, Han Zhou, Yanfang Liu, 2022, Bioorganic chemistry.

Structure-Activity Relationship Studies of Coumarin-like Diacid Derivatives as Human G Protein-Coupled Receptor-35 (hGPR35) Agonists and a Consequent New Design Principle.

Xinmiao Liang, Han Zhou, Xiuli Zhang, 2021, Journal of Medicinal Chemistry.

Aminosalicylates target GPR35, partly contributing to the prevention of DSS-induced colitis.

Xinmiao Liang, Han Lin, Han Zhou, 2023, European journal of pharmacology.

Development and Characterization of Fluorescent Probes for the G Protein-Coupled Receptor 35.

Xinmiao Liang, Han Zhou, Jixia Wang, 2023, ACS medicinal chemistry letters.

Structurally diverse isoquinoline and amide alkaloids with dopamine D2 receptor antagonism from Corydalis bungeana.

Han Zhou, Jia-tao Feng, Yanfang Liu, 2022, Fitoterapia.

Menisperdaurines A-W, structurally diverse isoquinoline alkaloids from Menispermum dauricum and their dopamine D1 receptor activities.

Han Zhou, Jixia Wang, Yaopeng Zhao, 2022, Bioorganic chemistry.

The dual-targeting mechanism of an anti-inflammatory diarylheptanoid from Curcuma zedoaria (Christm.) Roscoe with the capacity for β2-adrenoreceptor agonism and NLRP3 inhibition.

Han Zhou, Jixia Wang, Tao Hou, 2023, Chemico-biological interactions.

N-desmethyldauricine from Menispermum dauricum DC suppresses triple-negative breast cancer growth in 2D and 3D models by downregulating the NF-κB signaling pathway.

Jixia Wang, Tao Hou, Yanfang Liu, 2024, Chemico-biological interactions.

Discovery of 2H-Chromen-2-one Derivatives as G Protein-Coupled Receptor-35 Agonists.

Ye Fang, Xinmiao Liang, Xiuli Zhang, 2017, Journal of medicinal chemistry.